Pulmonary artery to aorta ratio and risk of all-cause mortality in the general population: the Rotterdam Study Source: Eur Respir J, 49 (6) 1602168; 10.1183/13993003.02168-2016 Year: 2017
Pulmonary function is associated with pulmonary artery systolic pressure in the general population: The Rotterdam study Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology Year: 2013
CT measured pulmonary artery to aorta ratio as a predictor of pulmonary hypertension in COPD Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014
Variation in mortality from pulmonary hypertension by aetiology Source: International Congress 2015 – Pulmonary hypertension: management Year: 2015
Coronary artery calcification, epicardial fat burden, and cardiovascular events in COPD Source: International Congress 2015 – A more functional view of chest pathology Year: 2015
Pulmonary artery enlargement and mortality risk in moderate to severe COPD: results from COPDGene Source: Eur Respir J, 55 (2) 1901812; 10.1183/13993003.01812-2019 Year: 2020
Macitentan reduces the risk of morbidity and mortality irrespective of the presence or absence of right ventricular (RV) impairment: Results from the randomised SERAPHIN trial in pulmonary arterial hypertension (PAH) Source: International Congress 2014 – Pulmonary hypertension: improving treatment in PAH Year: 2014
Circulating desmosine relates to cardiovascular comorbidity, coronary artery calcification score (CACS), systemic inflammation and mortality in patients with COPD Source: International Congress 2014 – Molecular pathogenesis of pulmonary inflammatory diseases (COPD, asthma and ILD) Year: 2014
Survival in pulmonary hypertension in Spain: insights from the Spanish registry}, Source: Eur Respir J 2012; 40: 596-603 Year: 2012
Chronic obstructive pulmonary disease (COPD) exacerbations and carotid artery plaques: The Rotterdam study Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts Year: 2013
The prevalence and characteristics of pulmonary hypertension in severe COPD Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016
ASPIRE registry: Assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre Source: Eur Respir J 2012; 39: 945-955 Year: 2012
Quality of life of patients with pulmonary arterial hypertension associated with congenital heart disease: The multicenter cross-sectional ACHILLE study Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014
Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model Source: Eur Respir J, 50 (2) 1700740; 10.1183/13993003.00740-2017 Year: 2017
Observational retrospective study on the treatment of pulmonary hypertension (PH) associated to pulmonary disease in patient with PH out of proportion Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013
The management and follow-up of pulmonary embolism (PE) at a district general hospital: Are we missing CTEPH? Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013
The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension Source: Eur Respir J 2012; 39: 589-596 Year: 2012
Age is independently associated with pulmonary arterial compliance in health and in patients with pulmonary vascular disease Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016
Cardiopulmonary MR characteristics can estimate mPAP in COPD Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016
An epidemiological study of pulmonary arterial hypertension in Japan Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015